Ruchita Sinha
InvestorGeneral Partner at AV8 Ventures
San Francisco Bay Area
Writes $500K – $5M checks · typically $2M
FoundedBrave Care · YC
About
Ruchita Sinha combines deep cellular and molecular biology training with an MBA in finance and Sanofi‑Genzyme BioVentures leadership experience to offer technical, pharma-focused guidance on company and clinical program design.
Invests in
AI & Machine LearningBiotechDigital HealthEnterprise SoftwareFintechHealthtechInsurTech
Experience
- ARTIS VenturesSenior Partnercurrent2025 — present
- AV8 VenturesVenture Partnercurrent2019 — presentSan Francisco Bay Area
- SanofiSr. Director of Investments2016 — 2019
- GE VenturesDirector, GE Ventures2013 — 2016Menlo Park, CA
- Pfizer PharmaceuticalsDirector, Strategy, Portfolio Management, and Commercial Operations2010 — 2013Greater New York City Area
- L.E.K. ConsultingSr. Consultant2007 — 2010Greater New York City Area
- MaxygenResearch Associate2001 — 2005San Francisco Bay Area
Education
- The University of Chicago Booth School of BusinessMBA, Finance and Entreprenuership2005 — 2007
- University of Wisconsin-MadisonMaster of Science - MS, Cell/Cellular and Molecular Biology
- Mount Holyoke CollegeBS, Biochemistry
Skills & more
Business Strategy23Venture Capital10Mergers1Business Development9Marketing Strategy2Cross-functional Team Leadership24Biotechnology8Management Consulting2LifesciencesCorporate Development1Due Diligence2Valuation
+12 more
Financial ModelingProduct DevelopmentCompetitive AnalysisStart-upsMarket AnalysisTechnology TransferMergers & AcquisitionsMedical DevicesStrategyStrategic PlanningPharmaceutical IndustryLife SciencesFrom Ruchita's professional profile.
Same school
Also attended The University of Chicago Booth School of Business442
Prashant ShahPartner at Monta Vista CapitalNoorPartner at Clear VenturesTinaInvestments & Portfolio Services Team Member at Clear VenturesKatrin GeyskensExecutive Director at Capricorn Venture PartnersBill PescatelloInvestor at LightbankGlebFounder and Managing Partner at iTech Capital
+ 436 more
Also attended University of Wisconsin-Madison194
Zhenyu TangInvestment Director at Intel CapitalDougAdvisor at Clear VenturesDan RuchPartner at Rho VenturesGeorge RobertsInvestor at OpenView Venture PartnersKevin WenzelAssociate at Marlin Equity PartnersSaar GurGeneral Partner at CRV (Charles River Ventures)
+ 188 more
Also attended Mount Holyoke College17
Maria CirinoInvestor at .406 VenturesKelci HoranOffice Manager and Executive Assistant at .406 VenturesKleida MartiroManaging Director at Glasswing VenturesErin HalbrechtHead of Marketing, Platform, & Operations at Sorenson VenturesDeborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesYan YanInvestment Associate at TDK Ventures
+ 11 more
Shared employers
Also worked at ARTIS Ventures8
Ameena El-BibanyVenture Partner at Page One VenturesStuart PetersonManaging Partner at Artis VenturesAustin WalneSenior Partner at Artis VenturesNiraj MehtaPartner at Artis VenturesHenry KlingensteinPartner at Artis VenturesOmair KhanPartner at Artis Ventures
+ 2 more
Also worked at Sanofi84
Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesMatt VineSenior Associate at RRE VenturesWalter OlesiakOperating Partner at RDiscoveryRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda VenturesCarlos Garcia-EcheverriaVenture Partner at Ysios Capital
+ 78 more
Also worked at Pfizer Pharmaceuticals124
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesBriggs MorrisonEntrepreneur Partner at MPM BioImpact
+ 118 more
Also worked at L.E.K. Consulting116
Chris BischoffInvestment Team at General CatalystMattias LjungmanInvestor at Moonfire VenturesJessica SchultzPartner at NorthzoneFrancois PrinslooInvestor at MedicxiMiranda GuerreroExecutive Assistant at Sapphire VenturesStacey HeroInvestor at Third Rock Ventures
+ 110 more
Investments
Investor
AetionClick TherapeuticsCommon SensingCurisiumEvidation HealthInozymeOmada HealthScience 37
Per the firm's website.
Colleagues at AV8 Ventures
Alexander Statnikov
Investor at AV8 Ventures
Anna Binder
Investor at AV8 Ventures
Baris Aksoy
General Partner at AV8 Ventures
Brett Battles
Partner at AV8 Ventures
Brian Kissel
Investor at AV8 Ventures
Dr. Gloria Lau
Investor at AV8 Ventures
Dr. Marco Pavone
Investor at AV8 Ventures
Gemma Garriga
Investor at AV8 Ventures
Network1
Investors connected to Ruchita in public investor directories — a warm-intro map.
























)









.jpg)











